Volume 7 Issue 304
Published - 14:00 UTC 08:00 EST 17-Nov-2005 
Next Update - 14:00 UTC 08:00 EST 18-Nov-2005

Editor: Susan K. Boyer, RN
All rights reserved.

We subscribe to the HONcode principles. Verify here.



Pain that brings us to our knees a great debate on a bone of contention

Pain caused by the kneecap, medically known as the patella, is a challenge to treat with the best treatment approach still to be identified. more  

Actemra monotherapy significantly slows down damage to joints in patients with early aggressive RA

Roche today announced the results of the first Phase III study in rheumatoid arthritis (RA) conducted by Chugai in Japan which are being presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Diego, USA. These data conclude for the first time that Actemra in monotherapy shows superiority to conventional disease modifying anti-rheumatic drugs (DMARDs) in inhibiting radiographic progression of joint destruction. The data also show Actemra dramatically improves the painful and disabling symptoms of patients with rheumatoid arthritis. more

New gene silencing therapy for cervical cancer

Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. more  

International multi-center study confirms value of blood test to diagnose heart failure

A large-scale international study has demonstrated the usefulness of a blood test to confirm or exclude the diagnosis of acute heart failure in emergency room patients and shows that the test also can identify patients at a higher risk for death. The report from investigators in the U.S., the Netherlands, Spain and New Zealand also clarifies the importance of age-specific levels of a protein called NT-proBNP that definitively diagnose heart failure. The report will appear in the European Heart Journal and is receiving early online release. more

Statins may simulate stem cells for heart repair  

The drug pravastatin, which is used widely to decrease high cholesterol, may provide a previously unknown cardiovascular benefit in addition to lowering lipids. more

Ozone levels may raise risk of underweight births  

Babies born to women exposed to high ozone levels during pregnancy are at heightened risk for being significantly underweight, according to researchers at the Keck School of Medicine of the University of Southern California. more

Illegal drug use could account for 1 million visits a year to emergency care in England

Illegal drug use could account for up to 1 million visits a year to emergency care departments and 400,000 admissions to hospital in England, suggests research in Emergency Medicine Journal. more


It is possible that illegal drugs contribute directly or indirectly to 1 million emergency department attendances and 40,000 acute hospital admissions in England each year